Suppression of saccadic intrusions in hereditary ataxia by memantine.
Serra
A
A
Veterans Affairs Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Liao
K
K
Martinez-Conde
S
S
Optican
L M
LM
Leigh
R J
RJ
D000328:Adult; D000368:Aged; D002524:Cerebellar Ataxia / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D002531:Cerebellum / Q000033:anatomy & histology / Q000187:drug effects / Q000503:physiopathology; D025063:Chromosome Disorders / Q000235:genetics / Q000503:physiopathology; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics; D015259:Dopamine Agents / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D005403:Fixation, Ocular / Q000187:drug effects / Q000502:physiology; D005808:Genes, Recessive / Q000235:genetics; D006801:Humans; D008297:Male; D008559:Memantine / Q000008:administration & dosage*; D008875:Middle Aged; D009434:Neural Pathways / Q000033:anatomy & histology / Q000187:drug effects / Q000503:physiopathology; D015835:Ocular Motility Disorders / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology*; D009801:Oculomotor Muscles / Q000294:innervation / Q000503:physiopathology; D012438:Saccades / Q000187:drug effects* / Q000502:physiology; D020754:Spinocerebellar Ataxias / Q000150:complications* / Q000503:physiopathology*; D016896:Treatment Outcome
D015259:Dopamine Agents; D008559:Memantine